Repeated, intermittent treatment of rats with amphetamine results in a sensitization of locomotor and stereotyped behaviors that is accompanied by an enhancement m stimulus-induced dopamme release Increased phosphorylatmn of the neural speclhC calmoduhn-blndlng protein, neuromoduhn F1) has been demonstrated In other forms of synaptlc plasticity and plays a role m neurotransmltter release To determine whether neuromoduhn phosphorylatmn was altered during amphetamine sensitization, the m wvo phosphorylated state of neuromoduhn was examined in rat strlatum m a post hoc phosphorylatmn assay Female, Holtzman rats received saline or 2 5 mg/kg amphetamine twice weekly for 5 weeks One week after the last dose of amphetamine, rats were challenged with either 1 mg/kg or 2 5 mg/kg amphetamine or sahne and the rats were sacrificed 30 mln later Purified synaphc plasma membranes were prepared in the presence of EGTA and okadalC acid to inhibit dephosphorylatlon, and were subsequently phosphorylated in the presence of purified protein klnase C and [y-a2P]ATP The protein kmase C-medmted post hoc phosphorylatmn of neuromoduhn was slgmficantly reduced in groups that received either acute or repeated amphetamine suggesting that neuromoduhn m those groups contained more endogenous phosphate The acute, challenge dose of amphetamine increased neuromoduhn phosphorylatmn in the sahne-treated controls but not in the repeated amphetamme-pretreated group Anh-neuromoduhn lmmunoblots showed no change m neuromodulln levels in any group There was no significant change in protein klnase C activity in any treatment group To further investigate the effect of acute amphetamine, the abdlty of amphetamine to alter neuromoduhn phosphorylatlon in 32p,-prelncubated Percoll-punfied rat strmtal synaptosomes was examined Amphetamine (10/xM) slgmflcantly increased phosphorylatlon of a 53 kDa band that,migrated with authenhc neuromoduhn In the synaptosomes by 22% while 500 nM 12-O-tetradecanoylphorbol 13-acetate (TPA) increased neuromoduhn phosphorylatmn by 45% These data suggest that one injection of amphetamine can increase neuromoduhn phosphorylatlon in rat strmtum and that this increase is maintained for at least 1 week following a repeated, sensitizing regimen of amphetamine Since sensltlzatlon can be reduced with one dose of amphetamine, it is possible that enhanced neuromoduhn phosphorylatlon could contribute to neurochemlcal events leading to enhanced release of dopamlne and/or behavioral senslttzahon
INTRODUCTION
In humans, amphetamine (AMPH) abuse can lead to a psychosis that clinically resembles paranoid schizophrenia and responds fairly rapidly to antlpsychotlc dopamme receptor blocking drugs Upon discontinuation of drug use, mdwiduals remain hypersensitive to the psychotic effects of the drug for several years 2'22'51's2'54 In animals, repeated, intermittent, administration of AMPH results in a sensitization of a number of behaviors, including locomotor and stereotyped behaviors (for review see ref 48) , that involve actwation of dopamlnerglc systems Behavioral sensitization to AMPH in rats can develop after only one reJection, but is more robust after multiple, intermittent, injections and will develop following a number of different injection regimens 46'4s After withdrawal from the drug, the sensitization intensifies with time and can persist for up to one year 4° Although considerable evidence suggests than an action of AMPH at dopamlne cell bodies m the mldbraln is necessary for induction of sensitization 13'23'56 the expression of AMPH sensitization resides in dopaminerglc terminal areas, such as strlatum and nucleus accumbens 2839'4648'58 An en-tenslficatlon with one dose, but hetghtened intensity upon multiple doses, increased acttvlty and persistence after withdrawal 3946485~ Enhanced AMPH-mduced dopamme release after repeated AMPH is expressed m both the rat stnatum and nucleus aecumbens and could play a role m the expresston of sensitization 46 4~ Behavtoral sensitization to AMPH exh~blts characteristics similar to other forms of synapttc plasticity, such as long-term potentmt~on, in that it develops after intermittent stimuli, ~s long-lastmg, involves an Increase m neurotransmltter release and ~ts induction is blocked by N-methyl-D-aspartate antagomsts 25 Addtttonal slm~lanttes m models of synaptlc plasttctty and AMPH-mduced behavioral sensltlzatton are morphological changes m pre-and postsynaptlc elements 4 7 ~i3 ,i7 and alterations m activities Involving Ca 2+ and/or the endogenous Ca2+-bmdmg protem, calmoduhn (CAM) 1~ 24 26 42 43 60 We and others have shown an increased CaM content and altered subcellular locahzatton of CaM m strlatum and llmb~c forebraln of rats repeatedly treated w~th AMPH 1~ 4143 50
Heightened phosphorylatlon in brain of a growth-associated, neural-specific. CaM-bmdlng protein termed neuromoduhn (as well as B-50, GAP-43, p57, F1, pp46, s) has been reported in several models of synaptic plasticity, such as long-term potentiation ~2 37 and memory formatton for passive avotdance m chicks 4~ Neuromoduhn is located presynaptlcally and plays a role m neuronal growth and neurotransmltter release ~ Neuromoduhn phosphorylatton has been correlated w~th neurotransmltter release from both synaptosome and slice preparatlonsl0tS Due to tts low charge-to-mass ratio neuromoduhn exhibits apparent molecular masses of between 43 and 67 kDa on SDS-polyacrylamtde gels. rather than its exact molecular mass of 24 kDa ~ Protem kmase C (PKC)-medlated phosphorylatlon of neuromoduhn or mcreased Ca 2+ leads to dlssocmt~on of CaM from neuromoduhn ~ It has been postulated that neuromoduhn sequesters CaM m the unsttmulated cell and releases tt upon an increase m mtracellular Ca 2+ and phosphorylat~on by PKC 3~ Since PKC-dependent phosphorylatlon of neuromoduhn has been correlated with synaptlc plasticity and may a play a role m neurotransmitter release and CaM locahzatlon m a cell, the phosphorylatlon of endogenous neuromoduhn m response to acute or repeated AMPH treatment was investigated To study neuromoduhn phosphorylat~on, the post hoc phosphorylat~on of neuromoduhn tn response to exogenous parttally-punfied PKC was assessed m purified rat strtatal synaptlc plasma membranes If enhanced neuromoduhn phosphorylatton is involved m behavtoral sensitization and/or the mcreased dopamme release m response to AMPH, one would predict that neuromoduhn phosphorylat~on would be greater after repeated treatment wtth AMPH and would persist following withdrawal ot the drug Enhanced phosphorylatlon of neuromodulm could also be detected after acute AMPH, since sensitization has been reported after a single dose of AMPH 4~ We found that neuromoduhn phosphorylatton was enhanced m stnatal synapttc plasma membranes lrom rats treated repeatedly with AMPH or m control rats that had received only one acute rejection of AMPH Prehmlnary studies show that AMPH could increase phosphorylatlon of a 53 kDa band m~gratmg with authentic neuromoduhn tn purified synaptosomes
MATERIALS AND METHODS

AMPH treatment
Female Holtzman rats ~ere treated w~th sahne (SAL) or 2 5 mg/kg AMPH l p twice weekly for 5 weeks One week after the repeated treatment a challenge dose of SAL or AMPH was admlmstered 30 mm before sacrifice such that 4 groups were formed SAL-SAL, SAL-AMPH, AMPH-SAL and AMPH-AMPH In Study 1 the challenge dose of AMPH was 1 mg/kg and m Study 2 the challenge dose was 2 5 mg/kg The lower challenge dose m Study 1 was chosen because the differences m sensitized behawor and AMPH-mduced dopamme release are accentuated after a lower challenge dose of AMPH (ref 47 , T E Robinson, personal commumcatlon) Th~s treatment regimen was shown to result m robust increases in rotational activity 4s
Preparattop o] ~vnapttc plaama membranes
Stnata were dissected within 60 s ol sacrifice and homogemzed m 0 32 M sucrose, 1 mM EGTA 2 mM Tns, pH 7 4, 10/~M leupeptm, 10 p,M pepstatm and 1 mM phenylmethylsulfonyl fluoride (PMSF) In Study 2 the medmm included 1 ~,M okadalc acid Synaptlc plasma membranes (SPM) were prepared as described by Dokas et al ~-" Briefly a P2 pellet prepared from an lndwldual stnatum (approximately 50-60 mg wet weight) was lysed, centrifuged at 10000× g for 20 mm washed and apphed to a sucrose gradient consisting o| 40 ml of 04 M sucrose overlaid on 8 ml ol l 0 M sucrose The gradient was centrifuged at 100,000× g for 80 mm m a Beckman SW27 rotor SPM's were collected by aspiration from the interface of the 0 4 M and 1 0 M layers, diluted 2-to 3-fold m 10 mM Tns-HCI, pH 7 5 and 1 mM EGTA and centrifuged m the SW 27 rotor at 100,000× g for 30 mln The hnal pellet was resuspended m 10 mM Tns buffer pH 7 5 Approximately 7/zg of SPM protein was obtained per mg wet weight t~ssue Post ho~ phosphorvlatton as~a~ PKC was purified from rat brain as described by I~htano et al 27 SPMs were phosphorylated m an assay containing 10 mM sodium acetate, pH 6 5, 10 mM magnesium acetate, 7 5 ~M [7-~2P]ATP (2 mCl/assay), 0 6/zg purified PKC, 0 1 mM CaCI 2 in a total volume of 75 /xl as described by Dokas et al ~2 After 30 s of incubation, the reaction was terminated by the addition one-third volume of an SDS-contammg stop solution containing 12 5 mM Tns-HCI, pH 6 8 4% SDS, 10% glycerol, 0 008% bromphenol blue and 40% mercaptoethanol In Study 1, SPMs were premcubated m assay buffer (10 mM sodmm acetate, pH 6 5, 10 mM magnesmm acetate and 0 1 mM CaCI 2) for 5 mm at 30 ° There was no premcubat~on in Stud~ 2 Samples were ~mmedlately subjected to SDS-PAGE on gels containmg either 10% or 8 75% polyacrylamlde as indicated with subsequent autorad~ography Results were analyzed by e~tber cutting the neuromoduhn band and counting the radloactw~ty or by scanning the films with a Hoefer GS365W scanning densltometer The total peak areas were quantified by Gausslan integration using the Hoefer GS365W electrophoresis data system Statistical significance was determined by one way analysis of varmnce (ANOVA) with post test Bonferroni t-test analysis calculated using GraphPad Instat Immunoblotttng SPM samples subjected to SDS-PAGE were electrophoretically transferred to Immobilon-P membranes for 2 h at 1 A at 4°C m a Transphor Transfer Unit (Hoefer Soentific) Blots were incubated in 10 mM Trls-HCI, pH 7 4, 150 mM NaCI with 0 I% Tween 20 and 1% (w/v) bovine serum albumin (blocking buffer) for 1-2 h at 4°C The Immobilon membrane was incubated overnight with affinity-purified antmeuromoduhn produced m rabbit (obtained from Dr Daniel Storm, Department of Pharmacology, University of Washington) diluted 1 1000 In blocking buffer 12sI-labeled donkey (1 mCi) antirabbit IgG or 125I-protem A (1 mCi) was used for quantification and autoradiography
PKC assay
PKC activity of the SPMs was measured using a synthetic substrate peptlde, myehn basic protem4_x4 (MBP4_I4), as described by Yasuda et Phosphorylatlon of the specltic PKC substrate MBP4_i4 was generally 4-5 times that of the non-peptlde containing blank PKC activity was also measured in the 10,000× g $2 supernatant fraction prepared from striata as described above using 200 ~g/ml hlstone H1 as substrate and 30 ~g of $2 protein 27 The PKC activity of the $2 fraction was determined to be the total activity (CaC12 plus hpids) minus that actwity measured m the presence of CaCl 2 All radloactwlty was determined using /3-scintillation counting in a Beckman LSS100
Phosphorylatton of Percoll-purtfied synaptosomes
Percoll-purified striatal synaptosomes from 4 rats were prepared as described by Dunkley et a114 Fractions 3 and 4, enriched with synaptosomes, were combined, washed and resuspended to a protein concentration of 2-3 mg/ml in oxygenated Krebs Ringer buffer (118 mM NaCI, 47 mM KCI, 12 mM CaC1 z, 12 mM MgCI2, 249 mM NaHCO 3, 10 mM glucose, oxygenated for 1 hr and brought to pH 7 4 at 37°C) Synaptosomes were prelabeled with 32p m (0 5 mCi/ml) for 45 mm at 37°C in Krebs-Ringer buffer The synaptosomes were then incubated with 10 gM AMPH, 500 nM 12-O-tetradecanoylphorbol 13-acetate (TPA) or buffer for 10 rain In some experiments synaptosomes were incubated with Krebs-Ringer buffer or high K + buffer (62 mM KCI and 85 7 mM NaCI) for 30 s The reaction was stopped with one-fourth volume of an SDS-buffer solution containing 200 mM Trls-HC1, pH 6 8, 8% SDS, 28% glycerol, 0 1% bromphenol blue, 77 mM mercaptoethanol and 6 mM EGTA and was subjected to SDS-PAGE on gels containing 8 75% polyacrylamlde with subsequent autoradlography Results were analyzed by either by scanning the peaks using a Hoefer GS365W scanning densitometer as described above or cutting the neuromoduhn band and counting the radioactivity The peak areas were quantified by Gausslan integration using the Hoefer GS365W electrophoresls data system Peak areas were always compared with those of controls run on the same gel Statistical significance was determined by one way analysis of variance (ANOVA) with posttest Bonferrom t-test analysis calculated using GraphPad Instat and by a two-tad Student's t-test or Wilcoxan signed-rank test 
Effect of EGTA on phosphorylatton of neuromoduhn
SPM preparations were used to assess phosphorylatlon of neuromoduhn because neuromoduhn is a prominent phosphorylated protem Jn SPM and ts readfly detected (Fig 1) The apparent molecular weight of neuromodulln on SDS-PAGE wJth 10% polyacrylamtde was 48 kDa In later experlments performed on 8 75% polyacrylamlde gels, which we found gave greater separation of the protems, neuromoduhn appeared to have a molecular weight of 51-53 kDa Dephosphorylatton of neuromoduhn durJng preparation of the SPMs, however, could confound the results The ablhty of EGTA to reduce the endogenous dephosphorylatJon of 2) regardless of whether the SPMs were prepared in the presence or absence of EGTA
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Post hoc phosphorylatton of neuromoduhn tn smatal SPMs prepared from rats given repeated, intermittent AMPH or SAL
The phosphorylated state of endogenous neuromoduhn was determined in strlatal SPMs prepared from rats treated intermittently with SAL or AMPH using the post hoc phosphorylatlon assay In Study 1, there was a decreased ability of neuromoduhn to be phosphorylated in the post hoc assay with purified PKC and [y-32p]ATP in SPMs prepared from rats receiving either acute treatment with 1 mg/kg AMPH or repeated treatment with 25 mg/kg AMPH Autoradlographs showing phosphorylatlon of SPMs from 3 different groups of rats are shown in Fig 3 To quantify the 32p mcorporated into neuromoduhn, the bands corresponding to purified neuromoduhn were cut and counted As shown in Table I , the 32p incorporation into those bands was significantly decreased in the SAL-AMPH, AMPH-SAL and AMPH-AMPH groups There was no significant difference In the 32p incorporation among any group that received AMPH The decrease in incorporation of 32p in the post hoc assay suggests that both acute and repeated AMPH treatment increased the in vivo phosphorylatlon of neuro- a Female Holtzman rats (n = 6) were treated with repeated saline (S) or amphetamine (A) and given a challenge dose of S or 1 mg/kg A before sacrifice as described lor Study 1 in Materials and Methods The first lmtlal represents the repeated treatment and the second represents the challenge treatment Bands in the SDS-PAGE corresponding to the Rf of purified NM were cut and counted after phosphorylatlon in the back-phosphorylatlon assay (32p) a~ were bands containing 125I-secondary antibody antibody from lmmunoblots For ~2p values ANOVA, P < 0 0001 In post analysis Bonferrom t-tests * P < 0 01 for A-S and A-A as compared to S-S and P <005 for S-A as compared to S-S 125I-values were not slgmflcantly different, ANOVA, P = 0 56 b Female Holtzman rats (n = 5) were treated with repeated amphetamine (A) or saline (S) and challenged with S or 2 5 mg/kg A as described for Study 2 m Materials and Methods Results were analyzed using densltometry as described in Materials and Methods For densltometry values P < 0 02 by ANOVA In post analysis Bonferrom t-test ** P < 0 05 for S-A and A-S as compared to S-S moduhn Although the challenge dose of 1 mg/kg AMPH was able to increase neuromoduhn phosphorylatlon In control SAL-treated rats, challenge with AMPH produced no further change in neuromoduhn phosphorylatton in rats repeatedly treated with AMPH To assess whether AMPH altered the amount of neuromoduhn in the SPMs, lmmunoblots were performed using affinity-purified antibody to neuromoduhn Neuromodulln lmmunoreactlvlty was detected with a25I-labeled donkey anti-rabbit IgG The lmmunoblots for neuromoduhn in the SPMs are shown above the SDS gels in Fig 3 Only one band was present upon lmmunoblottlng The bands were cut and counted and the results are shown in Table I The amount of ~mmuno-detectable neuromoduhn was not altered by AMPH treatment further indicating that the decreased 32p incorporation represents an alteration an the phosphorylated state of neuromoduhn In VlVO To further reduce dephosphorylatlon of neuromoduhn during preparation of SPMs as a factor in our results, the experiment was repeated including 1 p.M okadalc acid with 1 mM EGTA m SPM preparation buffers (Study 2) In addition, the challenge dose of acute AMPH was increased to 2 5 mg/kg to correspond with the dose of AMPH given repeatedly for 5 weeks The experiments were performed as described above but the results were analyzed by densltometry as described in Methods As shown m Table I , essentially the same results were achieved as those in Study 1 Fhe ablhty of neuromoduhn to be phosphorylated in the post hoc assay was reduced m SPMs from control rats recelvmg a challenge dose of 2 5 mg/kg AMPH or trom rats receiving repeated AMPH In this experiment, there was not a significant reduction in phosphorylatlon In the AMPH-AMPH group, but it demonstrated again that a challenge dose of AMPH does not ehclt further neuromoduhn phosphorylatlon in rats that have received repeated AMPH To determme whether the altered neuromoduhn phosphorylatlon was due to increased PKC activity, this acttvlty was measured m SPM and soluble fractions trom the four treatment groups PKC acttvtty m the SPMs was determined using the specific PKC substrate MBP4_I4 since very httle acttvtty could be measured using hlstone H1 as a substrate The PKC actlvtty in the SPMs was variable among the four groups but the results in Table II suggest that there was no stgnlflcant difference in PKC acttvlty among the groups Therefore neither repeated AMPH nor a challenge dose of AMPH appeared to alter the PKC activity To determine whether AMPH treatment would alter PKC acttvlty in general, PKC activity in the soluble $2 fraction
TABLE llI
Phosphorvlatlon of neuromoduhn by AMPH, TP4 and high K + in per~ oll-punfied rat stnatal synaptosomes
Percoll-purffled stnatal synaptosomes were eqmhbrated with ~:P, and incubated with 10 ~M AMPH, 500 nM TPA for 10 mm or 62 mM KCI for 30 s as described in Materials and Methods Results were analyzed by scanning the neuromoduhn band w~th densltometry as described m Materials and Methods a p < 0 007 as determined by a 2-tall pmred t-test b p < 0003 as determined by a 1-taft paired t-test ~ P < 0 008 as determined by a Wllcoxon s~gned rank test . AMI'H . .
Fig 4 A nt.uromoduhn phosphorvlatlon in Percoll-purlfied strlatal synaptosomes After equlhbratlon with ~2p~, synaptosomes were incubated with either buffer or 62 mM KCI for 30 s or buffer l0/zM AMPH or 500 nM TPA for 10 mm as described in Materials and Methods The reaction was stopped with SDS-stop buffer and subjected to SDS-PAGE on gels containing 8 75~ actvlamlde with subsequent autoradlography Lane 1 molecular weight markers Lane., "~ 5 ~g purified rat brain neuromoduhn Lane 3, buffer control, 30 s (C30") Lane 4 62 mM KCI, 30 s (K +) Lane 5 buffer control, 10 mm (Cl0") Lane 6 10 p,M AMPH l0 mm Lane 7, 500 nM TPA, l0 mln Under these condmons, purified neuromoduhn ran with an apparent molecular weight of 53 kDa B densltometnc scans of phosphoprotelns in lanes 5, 6 and 7, 10 mm incubation times with buffer (top), l0 pM AMPH (middle) or 500 nM TPA (bottom) The neuromodulln peak IS marked with a dotted line Results were analyzed by Gausslan integration with the GS365W densltometrlc program as described in Materials and Methods more directly, preliminary experiments were undertaken to examine the ability of AMPH to Increase neuromoduhn phosphorylatlon in an isolated synaptosomal preparation Percoll-purlfied synaptosomes were equilibrated with 32p, and then incubated with buffer, 10 #M AMPH or 500 nM TPA In one experiment, the effect of depolarization with high K + on neuromoduhn phosphorylatlon was assessed Phosphorylation of a 53 kDa band migrating with authentic neuromoduhn was assessed by scanning densltometry of the films and, in some experiments, by cutting the band from the gel and counting radioactivity The results in Table III show that l0/xM AMPH had some effect in increasing phosphorylatIon of the 53 kDa band Addition of 10 ~M AMPH to the synaptosomes significantly increased the phosphorylation of the 53 kDa neuromoduhn band by 25%. TPA averaged a 45% increase in phosphorylatlon of the 53 kDa neuromodulln band and K + depolarization increased the phosphorylatlon by 81% Shown in Fig 4A is Table III and show a significant Increase m phosphorylatlon of neuromoduhn by both AMPH and TPA In 5 of the AMPH experiments, the 32p-contaInlng 53 kDa neuromoduhn band was cut and counted Values for 32p In CPM were buffer, 307 _+ 52, AMPH, 385 + 72, p < 0 05 as determined by a 2-tailed Student's t-test DISCUSSION A post hoc phosphorylatlon assay was devised to determine the effect of repeated AMPH, gwen in an intermittent regimen that results in behavioral sensitization, on the in VlVO phosphorylated state of neuromoduhn in rat strlatum Our results suggest that one injection of AMPH can increase the phosphorylatlon of neuromoduhn and the heightened phosphorylatlon remains at least one week after withdrawal from a regimen of repeated, intermittent, AMPH The phosphorylated state after repeated AMPH appears 'maximal' and stable such that a challenge dose of AMPH 1 week later elicits no further change in phosphorylation of neuromoduhn Although dephosphorylatlon of neuromoduhn during preparation of SPMs could confound these results, our experiments suggested that inclusion of EGTA in the homogenization buffer reduced the dephosphorylatlon of neuromoduhn during SPM preparation These results are consistent with those of Melrl and Burdlck 35 who found that dephosphorylation of neuromoduhn in growth cones was prevented by EGTA but not okadaic acid Since, however, neuromoduhn has been shown to be dephosphorylated by protein phosphatases 1 and 2A 2° In synaptlc membranes, the experiment was repeated Including 1 /zM okadaic acid which would inhibit both phosphatases The results of both studies were comparable An alternative explanation of the data is that EGTA treatment could increase binding of endogenous CaM to neuromoduhn, which could block the post hoc phosphorylatlon of the protein However, th~s explanation is unlikely for two reasons First, strtata from SAL-and AMPH-treated animals were both homogenized with EGTA in exactly the same way Second, the prelncubatlon of membranes In a calcium-containing buffer in Study 1 should have dissooated endogenous CaM, permitting phosphorylatlon by PKC In Study 2, SPMs were not prelncubated to reduce the possibility of phosphatase action on endogenous neuromoduhn durIng the prelncubatlon period Results from Study 1 and Study 2 were essential the same
The post hoc assays were conducted using an excess of partially purified PKC Recent studies have shown that neuromoduhn in cultured neurons and In neonatal rat brain can be phosphorylated in VlVO at 3 sites, only one of which, serine 41, is phosphorylated by PKC 55 NeuromodulIn can be phosphorylated in vitro by casein kinase II 3 Phosphorylatlon at serlne 41 is important in the regulation of local concentrations of calmoduhn 31 and may play a role in modulating neurotransmltter releasel8 44 The relatively modest changes in phosphorylatlon could be due to the fact that not all neurons in the strlatum are affected by the acute or repeated AMPH, and the fact that only one-third of the possible phosphorylatlon sites in neuromoduhn are affected by PKC Although the n was low and the results variable, measurement of PKC activity suggested that AMPH treatment did not increase PKC activity It is possible that there is a transient increase in PKC elicited by AMPH that was not detected by our assay, or that a change in phosphatase activity IS responsible for the alteration of neuromoduhn phosphorylatlon
Many studies have demonstrated changes in neuromoduhn content, locahzation or phosphorylatlon associated with synaptic plasticity and nerve growth s'ls 3853 Increases in neuromoduhn phosphorylatlon have been shown to accompany long-term potentiation 1732'37 and the one-trial passive avoidance learning task in chicks 49 The molecular mechanisms by which neuromoduhn modifies synaptlc function in the adult brain, however, are unclear Although neuromoduhn is highly concentrated in areas such as the neocortex and hlppocampus s, neuromoduhn mRNA is also expressed at high levels m catecholamlnergic neurons in rat bralnstem s This strongly suggests that it is involved in physiological processes, such as neurotransmltter release, signal transductlon or other responses of functional plasticity, that regulate the synaptic function of the catecholamlnes There are several ways in which neuromoduhn could alter synaptlc function during AMPH sensitization One possible role is modulation of neurotransmitter release Enhanced stimulus-induced dopamlne release has been demonstrated in both rat stnatum and nucleus accumbens after repeated AMPH treatment Both AMPH-and Ca~+-requlrlng K +-stimulated release are increase& The increased dopamine releasablhty ~s expressed after a single injection of AMPH, is evident only after intermittent dosage regimens, persists for months after discontinuation of AMPH and is strengthened with greater time of withdrawal 464~ These characteristics are expressed by many behaviors in AMPH-lnduced sensmzatlon PKCmediated phosphorylatlon of neuromoduhn has been postulated to play a modulatory role in neurotransmltter release 1844 Phosphorylatlon of neuromoduhn can be stimulated by depolarization-dependent Ca -~+ influx, receptor activation or phorbol esters ~ 44 and has been correlated with neurotransmltter release from synaptosomes and hlppocampal shces TM In a study in streptolysln-O-permeablllzed synaptosomes, however, antl-neuromoduhn antibodies, which inhibit neuromoduhn phosphorylatlon by PKC, inhibited depolarization-evoked neurotransmltter release but not phorbol ester-reduced neurotransmltter release ~ This result must be interpreted with caution since neuromoduhn may not be revolved m mediation of release, but may have a role in priming or modulation of release 44 In addmon, permeablllzed synaptosomes, while retaining some function, may not maintain all functions of an untreated, healthier synaptosome The fact that an AMPH challenge had no further effect on neuromoduhn phosphorylatlon in rats repeatedly treated with AMPH supports the concept that neuromoduhn phosphorylatlon does not mediate the immediate release of dopamlne or the immediate expression of behavioral sensmzatlon An AMPH challenge given to rats sensatized to AMPH elicits enhanced dopamme release and an exaggerated behaworal response (see refs 47, 48) Although enhanced release of dopamlne may play a role m mediating the behavioral sensitization to AMPH, at is unlikely to be the sole mechanism underlying this phenomenon 2' Morphological changes in synapses also accompany expressions of synaptlc plasticity474957 Uranova et al 57 round an increase in the area ot presynaptlc terminals and length of postsynaptlc density in axodendritic and axo-splnous synapses m rat medial prefrontal cortex Similar studies were not performed m strlatum Neuromoduhn is primarily presynaptxc 18 in neurons and associated with a membrane skeleton m cells ~6 Although molecular events leading to morphological changes in synapses are not known, the known association of neuromoduhn with reactive synaptogenesis 3s and nerve growth suggests it could have a role in this process
Neuromoduhn could also affect signal transductlon in the neuron through its interaction with Go or its regulation of local CaM concentrations 8 A change m PKC-medlated phosphorylatlon of neuromoduhn may lead to increased available CaM in the neuron In vitro studies have shown that PKC-mediated phosphorylanon of neuromoduhn on serme 41 leads to a dissociation of CaM, since serlne 41 borders the CaM-binding site I Although a direct correlation between phosphorylatlon of serlne 41 in neuromoduhn and CaM dissociation has not been demonstrated in wvo, CaM has been shown to brad to neuromoduhn in membranes ' We have shown that stimulation of PKC leads to a membrane-to-cytosol redistribution of calmoduhn m human neuroblastoma SK-N-SH cells, which contain neuromoduhn ~4 An increase m CaM m the cell could lead to a rise m activation of various CaM-dependent enzymes An increase in neuromoduhn phosphorylatlon could enhance neurotransmitter release through dissociation of CaM, which would activate CaM-dependent protein kmase 1I (CaM-klnase II) CaM-klnase II, which has been locahzed in synaptosomes ~5, could increase the phosphorylatlon of the actln-blnding vesicle-associated protein, synapsin I Increased CaMKanase II-medlated phosphorylatlon of synapsln I has been demonstrated to increase neurotransmltter release 21 Phosphorylatlon of synapsln I releases the vesicle from cytoskeletal constraints and may allow more vesicles to migrate toward the active zone in the neuron We have demonstrated an increase in CaM in Percoll-purffled strlatal synaptosomes prepared from rats treated with repeated, intermittent, AMPH (Gnegy and Farrelk data not shown)
Our data suggest that AMPH could directly ehclt phosphorylatlon of a 53 kDa that migrated with authentic neuromoduhn an a synaptosomal preparation Even at 10 #M AMPH, the effect was modest as compared to that of TPA and high K + The mechanism by which this might occur is unknown TPA directly activates PKC and the K+-lnduced influx of Ca 2+ 
